Satoshi Hirano

28.2k total citations · 1 hit paper
477 papers, 8.0k citations indexed

About

Satoshi Hirano is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Satoshi Hirano has authored 477 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 283 papers in Surgery, 229 papers in Oncology and 195 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Satoshi Hirano's work include Pancreatic and Hepatic Oncology Research (153 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (101 papers) and Gallbladder and Bile Duct Disorders (85 papers). Satoshi Hirano is often cited by papers focused on Pancreatic and Hepatic Oncology Research (153 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (101 papers) and Gallbladder and Bile Duct Disorders (85 papers). Satoshi Hirano collaborates with scholars based in Japan, United States and Canada. Satoshi Hirano's co-authors include Toshiaki Shichinohe, Eiichi Tanaka, Takahiro Tsuchikawa, Satoshi Kondo, Satoshi Kondo, Yoshiyasu Ambo, Toru Nakamura, Hiroyuki Katoh, Takehiro Noji and Yuma Ebihara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Satoshi Hirano

430 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

2016 742 citations Masaru Konishi, Yasuhiro Shimizu et al. profile →

Peers

Satoshi Hirano

SURGE

ONCOL

PRM

EPIDE

Anton J. Bilchik United States

Ryan C. Fields United States

Ralf Kießlich Germany

Ross A. Abrams United States

Michael I. D’Angelica United States

Kim R. Geisinger United States

Neil A. Shepherd United Kingdom

Yoshihiro Sakamoto Japan

Harold J. Wanebo United States

J. Giralt Spain

Anton J. Bilchik United States

Satoshi Hirano

3.2k ×0.7

SURGE

5.3k ×1.1

ONCOL

1.6k ×0.5

PRM

1.2k ×1.1

EPIDE

1.3k ×1.4

Citations per year, relative to Satoshi Hirano Satoshi Hirano (= 1×) peers Anton J. Bilchik

Countries citing papers authored by Satoshi Hirano

Since Specialization

Citations

This map shows the geographic impact of Satoshi Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Hirano more than expected).

Fields of papers citing papers by Satoshi Hirano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Hirano. The network helps show where Satoshi Hirano may publish in the future.

Co-authorship network of co-authors of Satoshi Hirano

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Hirano. A scholar is included among the top collaborators of Satoshi Hirano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Hirano. Satoshi Hirano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morita, Ryo, Koji Yamasaki, Takaaki Fujii, et al.. (2024). Improvement of Hypoalbuminemia and Hepatic Reserve after Stent Placement for Postsurgical Portal Vein Stenosis. Journal of Vascular and Interventional Radiology. 36(4). 616–624.e2.

Ebihara, Yuma, Satoshi Hirano, Takahiro Kanno, et al.. (2023). Technical evaluation of robotic tele-cholecystectomy: a randomized single-blind controlled pilot study. Journal of Robotic Surgery. 17(3). 1105–1111. 5 indexed citations

Sasaki, Katsunori, Osamu Sato, Takahiro Tsuchikawa, et al.. (2023). Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model. Biomedicine & Pharmacotherapy. 170. 116052–116052. 5 indexed citations

Sasagawa, Shota, Hiroaki Kato, Todd A. Johnson, et al.. (2023). Immuno-genomic analysis reveals eosinophilic feature and favorable prognosis of female non-smoking esophageal squamous cell carcinomas. Cancer Letters. 581. 216499–216499. 8 indexed citations

Sato, Osamu, Takahiro Tsuchikawa, Takuma Kato, et al.. (2023). Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. Cancers. 15(3). 601–601. 11 indexed citations

Ebihara, Yuma, Satoshi Hirano, Yo Kurashima, et al.. (2023). Tele‐robotic distal gastrectomy with lymph node dissection on a cadaver. Asian Journal of Endoscopic Surgery. 17(1). e13246–e13246. 11 indexed citations

Kobayashi, Shogo, Masafumi Ikeda, Masaru Konishi, et al.. (2023). Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202. European Journal of Surgical Oncology. 50(2). 107324–107324. 3 indexed citations

Iwasaki, Yusuke, Todd A. Johnson, Chihiro Inai, et al.. (2022). Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer. Journal of Hepatology. 78(2). 333–342. 18 indexed citations

Tokunaga, Masanori, Takahiro Kanno, Kenji Kawashima, et al.. (2022). Maximum acceptable communication delay for the realization of telesurgery. PLoS ONE. 17(10). e0274328–e0274328. 27 indexed citations

10.

Hakamada, Kenichi, Hajime Morohashi, Harue Akasaka, et al.. (2022). Reappraisal of telesurgery in the era of high‐speed, high‐bandwidth, secure communications: Evaluation of surgical performance in local and remote environments. Annals of Gastroenterological Surgery. 7(1). 167–174. 11 indexed citations

11.

Hakamada, Kenichi, Hajime Morohashi, Harue Akasaka, et al.. (2022). Verification of delay time and image compression thresholds for telesurgery. Asian Journal of Endoscopic Surgery. 16(2). 255–261. 17 indexed citations

12.

Maki, Takehiro, et al.. (2021). Laparoscopic approach for surgical treatment of pleuroperitoneal communication interfering with peritoneal dialysis: a case report. SHILAP Revista de lepidopterología. 7(1). 217–217. 3 indexed citations

13.

Wada, Hideyuki, Katsuhiko Murakawa, Koichi Ono, & Satoshi Hirano. (2021). Laparoscopic ultrasound guided wedge resection of the stomach: a novel procedure for gastric submucosal tumor. Updates in Surgery. 74(1). 367–372.

14.

Fujita, Masashi, Shota Sasagawa, Kazuhiro Maejima, et al.. (2021). Molecular Classification and Tumor Microenvironment Characterization of Gallbladder Cancer by Comprehensive Genomic and Transcriptomic Analysis. Cancers. 13(4). 733–733. 16 indexed citations

15.

Tsuchikawa, Takahiro, Satoshi Takeuchi, Kimitaka Tanaka, et al.. (2021). Long-term survival after repetitive lymphadenectomy for nodal recurrence of pancreatic neuroendocrine neoplasms: a report of two cases. Journal of Surgical Case Reports. 2021(10). rjab446–rjab446.

16.

Asano, Toshimichi, Toru Nakamura, Takehiro Noji, et al.. (2020). Outcomes of limited resection for patients with intraductal papillary mucinous neoplasm of the pancreas: A single-center experience. Pancreatology. 20(7). 1399–1405. 5 indexed citations

17.

Hayashi, Hiroki, Jin‐Young Jang, Kyung Sik Kim, et al.. (2020). Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: A multi‐center collaborating study of Japan and Korea. Journal of Hepato-Biliary-Pancreatic Sciences. 27(6). 289–298. 9 indexed citations

18.

Kuwatani, Masaki, Toru Nakamura, Tsuyoshi Hayashi, et al.. (2019). Clinical Outcomes of Biliary Drainage during a Neoadjuvant Therapy for Pancreatic Cancer: Metal versus Plastic Stents. Gut and Liver. 14(2). 269–273. 22 indexed citations

19.

Hiraoka, Kei, Akihito Inagaki, Toshihiro Kushibiki, et al.. (2018). Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. Cancer Gene Therapy. 25(7-8). 184–195. 14 indexed citations

20.

Baghdadi, Muhammad, Takahiro Tsuchikawa, Haruka Wada, et al.. (2015). Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer. Cancer Research. 75(13). 2629–2640. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact